Vimarsana
Biggest News Aggregation in the World

Page 6 - Clinical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Sciences Today - Breaking & Trending Today

Jigawa, Gombe, 3 other states selected for hypertension treatment research - Vimarsana News

Jigawa, Gombe, 3 other states selected for hypertension treatment research

A collaborative academic research programme, Hypertension Treatment in Nigeria, which has enrolled over 23,000 patients with hypertension, is seeking to scale up its work to five new states in the country. Co-Principal Investigator, Hypertension Treatment in Nigeria Programme, Professor Mark Huffman of Washington University in St. Louis, USA and Dike…

Provost advises nursing graduands on integrity - Vimarsana News

Provost advises nursing graduands on integrity

The College of Medicine, University of Lagos, has advised its newly inducted nursing science students to make integrity, and trustworthiness their watchwords.

Gene Therapy Could Slow Aggressive ALS Progression - Vimarsana News

Gene Therapy Could Slow Aggressive ALS Progression

A groundbreaking gene therapy at Umeå University displays remarkable efficacy in decelerating the advancement of ALS in a patient with a severe form of the disease.

"e4life" is Present at Expomed Eurasia with its Innovative Device Able to Inactivate Flu and Covid Viruses With an Efficacy over 90% | Region - Vimarsana News

"e4life" is Present at Expomed Eurasia with its Innovative Device Able to Inactivate Flu and Covid Viruses With an Efficacy over 90% | Region

ISTANBUL--(BUSINESS WIRE)--Apr 19, 2024--

Heart attack: Beta-blockers have no significant benefit, study finds - Vimarsana News

Heart attack: Beta-blockers have no significant benefit, study finds

Researchers conducted a large trial to determine whether beta-blockers provide benefits in people with preserved ejection fraction after a myocardial infarction (heart attack). The findings show that beta-blockers had no significant benefit following a heart attack in people with normal heart function.